Showing 3,721 - 3,739 results of 3,739 for search '"MIDI"', query time: 0.22s Refine Results
  1. 3721
  2. 3722
  3. 3723

    Pathological risk factors for lymph node metastasis in patients with submucosal invasive colorectal carcinoma by Zhang Q, Wang L, Huang D, Xu M, Weng W, Ni S, Tan C, Sheng W

    Published 2019-01-01
    “…Qiongyan Zhang,1–3,* Lei Wang,1,2,* Dan Huang,1,2 Midie Xu,1,2 Weiwei Weng,1,2 Shujuan Ni,1,2 Cong Tan,1,2 Weiqi Sheng1,2 1Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; 3Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, China *These authors contributed equally to this work Background: Risk grade assessment determines therapy in patients with submucosal invasive colorectal carcinoma (CRC). …”
    Get full text
    Article
  4. 3724

    The Nrf2/HO-1 axis can be a prognostic factor in clear cell renal cell carcinoma by Deng Y, Wu Y, Zhao P, Weng W, Ye M, Sun H, Xu M, Wang C

    Published 2019-02-01
    “…Yu Deng,1,2,* Yong Wu,2,3,* Ping Zhao,4 Weiwei Weng,1,2 Min Ye,1,2 Hui Sun,1,2 Midie Xu,1,2 Chaofu Wang4 1Department of Pathology, Fudan University Shanghai Cancer Centre, Shanghai, China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 3Department of Gynaecologic Oncology, Fudan University Shanghai Cancer Centre, Shanghai, China; 4Department of Pathology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China *These authors contributed equally to this work Objective: To study the protein expression level of Nrf2/HO-1 in clear cell renal cell carcinoma (ccRCC) and adjacent normal tissue and to explore its relationship with clinicopathological characteristics and prognosis in ccRCC patients.Materials and methods: In total, 152 ccRCC patients with available follow-up and clinical data were enrolled, and sample microarrays were prepared for immunohistochemistry studies. …”
    Get full text
    Article
  5. 3725
  6. 3726
  7. 3727
  8. 3728
  9. 3729
  10. 3730
  11. 3731
  12. 3732
  13. 3733
  14. 3734
  15. 3735

    Screening of Breast Cancer Methylation Biomarkers Based on the TCGA Database by Wang X, Jia J, Gu X, Zhao W, Chen C, Wu W, Wang J, Xu M

    Published 2021-12-01
    “…Xuechun Wang,1,* Jia Jia,2,* Xuehong Gu,3 Wei-wei Zhao,4 Caiping Chen,5 Wanxin Wu,6 Jiayuan Wang,1 Midie Xu7 1Department of Laboratory, Jiaxing First Hospital, Jiaxing, 314000, People’s Republic of China; 2Shanghai Center for Bioinformation Technology, Shanghai, 201202, People’s Republic of China; 3Department of Nursing, Jiaxing First Hospital, Jiaxing, 314000, People’s Republic of China; 4Department of Rehabilitation Medicine, Jiaxing First Hospital, Jiaxing, 314000, People’s Republic of China; 5Department of Breast Surgery, Jiaxing First Hospital, Jiaxing, 314000, People’s Republic of China; 6Department of Pathology, Jiaxing First Hospital, Jiaxing, 314000, People’s Republic of China; 7Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xuehong GuDepartment of Nursing, Jiaxing First Hospital, No. 1882 of Central South Road, Jiaxing, 314000, People’s Republic of ChinaTel +86 13957368443Fax +86 573-83599079Email guxuehong145@163.comObjective: Breast cancer has become a fatal disease for women world-wide. …”
    Get full text
    Article
  16. 3736
  17. 3737
  18. 3738
  19. 3739